Semamed (10) vials 5mg-30mg

Semaglutide — New Zealand (10) vials.

Semaglutide is a synthetic peptide commonly studied in scientific and laboratory research involving glucagon-like peptide-1 (GLP-1) receptor signaling, glucose metabolism, appetite regulation, and related endocrine pathways.

As a GLP-1 receptor agonist, Semaglutide is of interest in research examining incretin signaling, metabolic regulation, insulin-related pathways, and energy balance.

Key Features

• Synthetic peptide

• GLP-1 receptor agonist

• Suitable for laboratory and analytical research

• Commonly studied in metabolic and endocrine research

• Relevant to incretin and glucose-regulation pathways

• Clearly labeled for research purposes

Important: This product is intended strictly for research purposes only. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.